Cargando…
Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States
BACKGROUND: This retrospective database analysis used data from the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample (NIS) to examine common primary diagnoses among children and adolescents hospitalized with a secondary diagnosis of attention- deficit/hyperactivity disorder...
Autores principales: | Meyers, Juliana, Classi, Peter, Wietecha, Linda, Candrilli, Sean |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019129/ https://www.ncbi.nlm.nih.gov/pubmed/21156063 http://dx.doi.org/10.1186/1753-2000-4-31 |
Ejemplares similares
-
Preferences related to attention-deficit/hyperactivity disorder and its treatment
por: Van Brunt, Kate, et al.
Publicado: (2011) -
Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009) -
Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
por: Kotsopoulos, Nikolaos, et al.
Publicado: (2013) -
Healthcare utilisation in the United Arab Emirates for children with attention-deficit hyperactivity disorder and comorbidities
por: Almai, Ahmad M., et al.
Publicado: (2023) -
Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial
por: Shaywitz, Sally, et al.
Publicado: (2017)